ExactAb™,低内毒素,已验证,无动物源,无叠氮钠,无载体,重组 级 提供 ≥95%(SDS-PAGE&SEC-HPLC) 纯度，适用于对基线干扰要求严格的色谱和分析工作流程。
-80℃储存,避免反复冻融。特低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Cofetuzumab (anti-CCK4) 是人源化的靶向 PTK7 的 IgG1-κ 单克隆抗体。Cofetuzumab (anti-CCK4) 的表达体系通常为 CHO (中国仓鼠卵巢) 细胞。
Cofetuzumab (anti-CCK4) is a humanized IgG1-κ monoclonal antibody targeting PTK7. The expression system of Cofetuzumab (anti-CCK4) is usually CHO (Chinese Hamster Ovary) cells.
Purity>95% (SDS-PAGE&SEC)
Endotoxin Level < 0.01EU/μg
Cofetuzumab (anti-CCK4) (Ab182763) - Flow Cytometry
Flow Cytometry analysis of MCF-7 cells labelling CCK4 (red) with Cofetuzumab (anti-CCK4) (Ab182763). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Cofetuzumab (anti-CCK4) (Ab182763) - Flow Cytometry
Flow Cytometry analysis of A431 cells labelling CCK4 (red) with Cofetuzumab (anti-CCK4) (Ab182763). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Cofetuzumab (anti-CCK4) (Ab182763) - Flow Cytometry
Flow Cytometry analysis of HeLa cells labelling CCK4 (red) with Cofetuzumab (anti-CCK4) (Ab182763). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Cofetuzumab (anti-CCK4) (Ab182763) - Flow Cytometry
Flow Cytometry analysis of A549 cells labelling CCK4 (red) with Cofetuzumab (anti-CCK4) (Ab182763). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Cofetuzumab (anti-CCK4) (Ab182763) - SEC
The purity of Cofetuzumab (anti-CCK4) (Ab182763) is more than 95% verified by HPLC.
通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
 ZJ24F0707797 |
分析证书 | Ab182763 |
| ZJ24F0707798 |
分析证书 | Ab182763 |
| ZJ24F0707799 |
分析证书 | Ab182763 |
我们的级别选择指南涵盖了目录中所有的变体的纯度、稳定剂状态和应用适用性。
查看 Animal Free 级别指南 → 查看 Carrier Free 级别指南 → 查看 Recombinant 级别指南 → 查看 Validated 级别指南 → 查看 ExactAb™ 级别指南 → 查看 Low Endotoxin 级别指南 → 查看 Azide Free 级别指南 →
危险品化学品经营许可证（带存储）